Newsletter | November 22, 2021

11.22.21 -- BRAAVE 2020: Engaging Black American Communities In HIV Clinical Research

 
Sponsor
Featured Editorial
Industry Insights
How Thoughtful, Strategic Design Improves The Patient Experience In Clinical Trials
A technology or solution created with thoughtful, strategic design will elevate the experience of the user. By applying the strength and worldwide reputation of IBM design to clinical trial technology, the company is set to revolutionize — and significantly improve — the experiences of both patients and site personnel.
Addressing Complications With End-Of-Study Media

Managing end-of-study media with CDs? Take a fully validated, digital approach to data archiving.

Six Key Principles From The World Health Organization (WHO) On The Use Of AI In Healthcare

These days, more and more companies employ automation technology in pharmacovigilance processes. The resource-intensive industry of pharmacovigilance and clinical safety is constantly looking to streamline processes with the help of software providers to reduce the costs of manual processes and increase program efficiency.

A Patient-First Approach: Reduce Patient Burden And Make The Most Of Valuable Data

A recent survey of pharmaceutical companies found that 52% of respondents have used activity trackers in clinical trials. And 65% plan to use them in the future. As these sponsors know, actigraphy data can be incredibly beneficial. But to fully capitalize on the technology, you need a detailed plan for how you’ll use it.

Top Six Countries For Rescuing Your Clinical Study

When your study is in trouble, choosing the right country can help get it back on track. While many countries can and should be considered, OCT Clinical discusses the countries they have experienced with regards to clinical trial rescue.

Investigator Payments: A Critical Component In Bayer’s Sponsor Of Choice Strategy

Year after year, slow and unpredictable investigator payments continue to be a top complaint from clinical study sites. Explore Bayer's Automated Site Payment Invoice Resolution project in the available white paper.

The Evolution Of The Modern Medical Monitor

How to identify, hire, and empower a modern medical monitor to help your next study proceed toward submission more productively, and with greater data integrity, than ever before.

Optimization Of The Comparator Sourcing Supply Chain

Developing a relationship with a U.S.-based sourcing and warehouse leader was a critical element in Client-Pharma’s commitment to providing the shortest possible sourcing and logistics supply chain for distributing comparator drugs to U.S. clinical trial sites.

Large Pharma Alzheimer's Disease Decentralized Clinical Trial

A pharmaceutical company is conducting a large clinical trial to evaluate its Alzheimer’s disease therapy in older adults. Because the sponsor wanted to conduct assessments remotely, it needed a data capture platform that would facilitate complex central nervous system (CNS) electronic clinical outcome assessments (eCOA) via telehealth.

AI-Assisted Indexing Improves Trial Master File (TMF) Management

The timely and accurate filing and indexing of documents for the trial master file (TMF) is one of the most significant compliance challenges facing organizations today. In this case study, learn how Phlexglobal’s advanced machine learning technologies reduced a pharmaceutical company’s document processing time by 16% while maintaining 98% accuracy.

The Role Of Genomics In Clinical Trials

Genomics has come a long way from the days of being primarily a discovery tool. It used to be that essentially all the genomic data that were being produced as part of clinical trials were purely exploratory in nature. This is still being done, but now we're also translating those insights into real uses. In this podcast we discuss the use of broad genomic features such as microsatellite instability and tumor mutational burden as biomarkers in addition to specific point mutations that have been in use for some time.

Does Your Clinical Trial Design Satisfy The Needs Of Your Patients?

While the patient-centric design of decentralized trials increases convenience and provides an uninterrupted flow of medication for the patient, it can also positively impact trial enrollment and retention for sponsors.

Creating An Integrated Digital Pathway For Sites And Sponsors

View this webinar to find out how Cognizant® Shared Investigator Platform (SIP) deeply integrated with the leading eISF solution automates the flow of documents connecting to sponsor electronic trial master file (eTMF) systems, enhancing site-sponsor collaboration, compounding efficiencies, and accelerating trials.

What Can An Advanced Digital Platform Bring To Decentralized Clinical Trials?

In this video, Edward Triebell, executive director, product development of digital health, shares the key considerations around implementing technology and technological elements within clinical trials, recommendations on the best practices for integrating new systems and technologies, as well as what the future looks like when it comes to technology and decentralized trials.

Solutions
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.